ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ARCC Ares Capital Corporation

20.77
0.14 (0.68%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ares Capital Corporation NASDAQ:ARCC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.14 0.68% 20.77 20.25 21.99 20.84 20.64 20.68 2,640,447 05:00:05

Current Report Filing (8-k)

18/01/2022 9:31pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported) January 18, 2022

 

ARES CAPITAL CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

Maryland 814-00663 33-1089684

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

245 Park Avenue, 44th Floor, New York, NY 10167
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code (212) 750-7300

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol Name of each exchange on which registered
Common stock, $0.001 par value ARCC NASDAQ Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 8.01. Other Events.

 

On January 18, 2022, Ares Capital Corporation (the “Company”) issued 10,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, pursuant to a Purchase Agreement, dated January 12, 2022 (the “Purchase Agreement”), among the Company, Ares Capital Management LLC, Ares Operations LLC and Morgan Stanley & Co. LLC, BofA Securities, Inc. and UBS Securities LLC, as representatives of the several underwriters named on Schedule A thereto (collectively, the “Underwriters”). In addition, under the terms of the Purchase Agreement, the Company granted the Underwriters an option to purchase an additional 1,500,000 shares of Common Stock, exercisable for 30 days from the date of the Purchase Agreement.

 

The Shares were purchased by the Underwriters from the Company at a price of $21.06 per share, resulting in net proceeds to the Company of approximately $210.2 million, after deducting discounts and commissions and estimated offering expenses.

 

The Shares were offered and sold pursuant to the Registration Statement on Form N-2 (File No. 333-256733) and a prospectus supplement and accompanying prospectus, dated January 13, 2022, filed with the Securities and Exchange Commission.

 

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, filed as Exhibit 1.1 hereto and incorporated by reference herein.

 

  2  

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit
Number
  Description
1.1   Purchase Agreement, dated as of January 12, 2022, among Ares Capital Corporation, Ares Capital Management LLC, Ares Operations LLC and Morgan Stanley & Co. LLC, BofA Securities, Inc. and UBS Securities LLC, as representatives of the several underwriters named on Schedule A thereto  
     
5.1   Opinion of Venable LLP
     
23.1   Consent of Venable LLP (contained in the opinion filed as Exhibit 5.1 hereto)

 

  3  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ARES CAPITAL CORPORATION
Date: January 18, 2022  
  By: /s/ Penni F. Roll
  Name: Penni F. Roll
  Title: Chief Financial Officer

 

 

 

1 Year Ares Capital Chart

1 Year Ares Capital Chart

1 Month Ares Capital Chart

1 Month Ares Capital Chart

Your Recent History

Delayed Upgrade Clock